
The past decade has witnessed tremendous advances in the discovery and development of novel zzso zzso targeting zzso pathways for cancer treatment, with some compounds now in clinical zzso Early promising clinical data have been reported with these new classes of zzso zzso This review highlights the recent zzso in the development of zzso zzso targeting three major classes of zzso zzso zzso B cell zzso 2 zzso zzso inhibitor of zzso proteins zzso and zzso zzso 2 zzso Special emphasis is given to those that have been advanced into clinical zzso The challenges and future directions in the further zzso and clinical development of these new zzso drugs are also zzso 

